Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,742
Closed -$237K 1311
2025
Q4
$237K Sell
4,742
-3,172
-40% -$152K ﹤0.01% 1086
2025
Q3
$388K Sell
7,914
-167
-2% -$8.56K 0.01% 917
2025
Q2
$418K Buy
8,081
+1,267
+19% +$58.2K 0.01% 879
2025
Q1
$312K Buy
6,814
+209
+3% +$10.8K 0.01% 922
2024
Q4
$338K Buy
6,605
+1,392
+27% +$72.1K 0.01% 907
2024
Q3
$209K Sell
5,213
-712
-12% -$31.1K 0.01% 997
2024
Q2
$238K Buy
5,925
+712
+14% +$27K 0.01% 975
2024
Q1
$209K Buy
+5,213
New +$196K 0.01% 996

Other funds holding SNV

Ethic Inc's SNV Position: Q1 2026 in Review

Ethic Inc sold out of Synovus (SNV) in Q1 2026, closing a stake of 4,742 shares — an estimated $237K sold.

Ethic Inc first reported a position in SNV in Q1 2024 and held it in 8 quarters. The position peaked at $418K in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Ethic Inc reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Ethic Inc sold 4,742 Synovus shares in Q1 2026, an estimated $237K.
  • Ethic Inc first reported a position in Synovus in Q1 2024 and held it in 8 quarters.
  • Ethic Inc's Synovus position peaked at $418K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.